Drug release from matrix tablets: physiological parameters and the effect of food

Bibliography

• Yu ZL, Schwartz JB, Sugita ET. Theophylline controlled-release formulations: in vivo-in vitro correlations. Biopharm Drug Dispos 1996;17:259-72
   PubMed Web of Science ®Google Scholar
• Grundy JS, Anderson KE, Rogers JA, et al. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system 2 improved in vitro-in vivo correlation using a two-phase dissolution test. J Control Release 1997;48:9-17
   Web of Science ®Google Scholar
• Soderlind E, Karlsson E, Carlsson A, et al. Simulating fasted human intestinal fluids: understing the roles of lecithin bile acids. Mol Pharm 2010;7:1498-507
   PubMedGoogle Scholar
• Mudie DM, Amidon GL, Amidon GE. Physiological parameters for oral delivery in vitro testing. Mol Pharm 2010;7:1388-405
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernas H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification – the correlation of in-vitro drug product dissolution in-vivo bioavailability. Pharm Res 1995;12:413-20
   PubMed Web of Science ®Google Scholar
• Asare-Addo K, Levina M, Rajabi-Siahboomi AR, et al. Study of dissolution hydrodynamic conditions versus drug release from hypermelose matrices: the influence of agitation sequence. Colloids Surf B Biointerfaces 2010;81:452-60
   PubMed Web of Science ®Google Scholar
• Asare-Addo K, Levina M, Rajabi-Siahboomi AR, et al. Effect of ionic strength pH of dissolution media on theophylline release from hypromellose matrix tablets – apparatus USP III, simulated fasted fed conditions. Carbohydr Polym 2011;86:85-93
   Web of Science ®Google Scholar
• Asare-Addo K, Kaialy W, Levina M, et al. The influence of agitation sequence ionic strength on in-vitro drug release from hypromellose (E4 M K4 M) ER matrices - the use of the USP III apparatus. Colloids Surf B Biointerfaces 2013;104:54-60
   PubMed Web of Science ®Google Scholar
• Asare-Addo K, Conway BR, Larhrib H, et al. The effect of pH ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices. Colloids Surf B Biointerfaces 2013;111:384-91
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Raja S, Patel P, et al. The role of oral controlled release matrix tablets in drug delivery systems. Bioimpacts 2012;2:175-87
   PubMedGoogle Scholar
• Ritschel WA. Targeting in the gastrointestinal-tract - new approaches. Methods Find Exp Clin Pharmacol 1991;13:313-36
   PubMed Web of Science ®Google Scholar
• Bergström CA, Holm R, Jørgensen SA, et al. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. Eur J Pharm Sci 2014;57:173-99
   PubMed Web of Science ®Google Scholar
• Dressman JB, Amidon GL, Reppas C, et al. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res 1998;15:11-22
   PubMed Web of Science ®Google Scholar
• Sheng JJ, Kasim NA, Chrasekharan R, et al. Solubilization dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant. Eur J Pharm Sci 2006;29:306-14
   PubMed Web of Science ®Google Scholar
• Li CL, Martini LG, Ford JL, et al. The use of hypromellose in oral drug delivery. J Pharm Pharmacol 2005;57:533-46
   PubMed Web of Science ®Google Scholar
• Phaechamud T, Ritthidej GC. Sustained-release from layered matrix system comprising chitosan. Drug Dev Ind Pharm 2007;33:595-605
   PubMed Web of Science ®Google Scholar
• Efentakis M, Dressman JB. Gastric juice as a dissolution medium: surface tension and pH. Eur J Drug Metab Pharmacokinet 1998;23:97-102
   PubMed Web of Science ®Google Scholar
• Pedersen BL, Müllertz A, Brøndsted H, et al. A comparison of the solubility of danazol in human and simulated gastrointestinal fluids. Pharm Res 2000;17:891-4
   PubMed Web of Science ®Google Scholar
• Kalantzi L, Persson E, Polentarutti B, et al. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents. Pharm Res 2006;23:1373-81
   PubMed Web of Science ®Google Scholar
• AstraZeneca, data on file. Communication with Bertil Abrahamsson och Anders Borde
   Google Scholar
• Dressman JB, Berardi RR, Dermentzoglou LC, et al. Upper gastrointestinal (gi) ph in young, healthy-men women. Pharm Res 1990;7:756-61
   PubMed Web of Science ®Google Scholar
• Kalantzi L, Goumas K, Kalioras V, et al. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res 2006;23:165-76
   PubMed Web of Science ®Google Scholar
• Lindahl A, Ungell AL, Knutson L, et al. Characterization of fluids from the stomach proximal jejunum in men women. Pharm Res 1997;14:497-502
   PubMed Web of Science ®Google Scholar
• Dressman JB, Berardi RR, Dermentzoglou LC, et al. Upper gastrointestinal (gi) ph in young, healthy-men women. Pharm Res 1990;7:756-61
   PubMed Web of Science ®Google Scholar
• Annaert P, Brouwers J, Bijnens A, et al. Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support age-dependent oral drug absorption. Eur J Pharm Sci 2010;39:15-22
   PubMed Web of Science ®Google Scholar
• Perez de la Cruz Moreno M, Oth M, Deferme S, et al. Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum. J Pharm Pharmacol 2006;58:1079-89
   PubMed Web of Science ®Google Scholar
• Benn A, Cooke WT. Intraluminal pH of duodenum and jejunum in fasting subjects with normal and abnormal gastric or pancreatic function. Scand J Gastroenterol 1971;6:313-17
   PubMed Web of Science ®Google Scholar
• Clarysse S, Tack J, Lammert F, et al. Postprial evolution in composition characteristics of human duodenal fluids in different nutritional states. J Pharm Sci 2009;98:1177-92
   PubMed Web of Science ®Google Scholar
• Brouwers J, Tack J, Lammert F, et al. Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: a case study with amprenavir. J Pharm Sci 2006;95:372-83
   PubMed Web of Science ®Google Scholar
• Kossena GA, Charman WN, Wilson CG, et al. Low dose lipid formulations: effects on gastric emptying and biliary secretion. Pharm Res 2007;24:2084-96
   PubMed Web of Science ®Google Scholar
• Psachoulias D, Vertzoni M, Goumas K, et al. Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults. Pharm Res 2011;28:3145-58
   PubMed Web of Science ®Google Scholar
• Youngberg CA, Berardi RR, Howatt WF, et al. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Dig Dis Sci 1987;32:472-80
   PubMed Web of Science ®Google Scholar
• Watson BW, Meldrum SJ, Riddle HC, et al. pH profile of gut as measured by radiotelemetry capsule. Br Med J 1972;2:104-6
   PubMed Web of Science ®Google Scholar
• Ovesen L, Bendtsen F, Tagejensen U, et al. Intraluminal pH in the stomach, duodenum, proximal jejunum in normal subjects patients with exocrine pancreatic insufficiency. Gastroenterology 1986;90:958-62
   PubMed Web of Science ®Google Scholar
• Armand M, Borel P, Pasquier B, et al. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am J Physiol 1996;271:G172-83
   PubMed Web of Science ®Google Scholar
• Mansbach CM, Cohen RS, Leff PB. Isolation and properties of the mixed lipid micelles present in intestinal content during fat digestion in man. J Clin Invest 1975;6:781-91
   Google Scholar
• Vertzoni M, Markopoulos C, Symillides M, et al. Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of Danazol across Caco-2 cell monolayers. Mol Pharm 2012;9:1189-98
   PubMed Web of Science ®Google Scholar
• Persson EM, Gustafsson AS, Carlsson AS, et al. The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids. Pharm Res 2005;22:2141-51
   PubMed Web of Science ®Google Scholar
• Sheng JJ, McNanara DP, Amidon GL. Toward an in vivo dissolution methodology: a comparison of phosphate bicarbonate buffers. Mol Pharm 2009;6:29-39
   PubMed Web of Science ®Google Scholar
• Fadda HM, Sousa T, Carlsson AS, et al. Drug solubility in luminal fluids from different regions of the small large intestine of humans. Mol Pharm 2010;7:1527-32
   PubMedGoogle Scholar
• Cummings JH, Pomare EW, Branch WJ, et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987;28:1221-7
   PubMed Web of Science ®Google Scholar
• Cummings JH. Colonic absorption: the importance of short chain fatty acids in man. Scand J Gastroenterol Suppl 1984;93:89-99
   PubMedGoogle Scholar
• Ladas SD, Isaacs PE, Murphy GM, et al. Fasting and postprandial ileal function in adapted ileostomates and normal subjects. Gut 1986;27:906-12
   PubMed Web of Science ®Google Scholar
• Kanaghinis T, Lubran M, Coghill NF. The composition of ileostomy fluid. Gut 1963;4:322-38
   PubMed Web of Science ®Google Scholar
• Clarysse S, Psachoulias D, Brouwers J, et al. Postprial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs. Pharm Res 2009;26:1456-66
   PubMed Web of Science ®Google Scholar
• Pedersen PB, Vilmannb P, Bar-Shalom D, et al. Characterization of fasted human gastric fluid for relevant rheological parameters and gastric lipase activities. Eur J Pharm Biopharm 2013;85:958-65
   PubMed Web of Science ®Google Scholar
• Jantratid E, Janssen N, Reppas C, et al. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res 2008;25:1663-76
   PubMed Web of Science ®Google Scholar
• Dikeman CL, Fahey GC Jr. Viscosity as related to dietary fiber: a review. Crit Rev Food Sci Nutr 2006;46:649-63
   PubMed Web of Science ®Google Scholar
• Marciani L, Gowl PA, Spiller RC, et al. Gastric response to increased meal viscosity assessed by echo-planar magnetic resonance imaging in humans. J Nutr 2000;130:122-7
   PubMed Web of Science ®Google Scholar
• Malkki Y. Physical properties of dietary fiber as keys to physiological functions. Cereal Foods World 2001;46:196-9
   Web of Science ®Google Scholar
• Abrahamsson B, Pal A, Sjöberg M, et al. A novel in vitro and numerical analysis of shear-induced drug release from extended-release tablets in the fed stomach. Pharm Res 2005;22:1215-26
   PubMed Web of Science ®Google Scholar
• Kwiatek MA, Menne D, Steingoetter A, et al. Effect of meal volume calorie load on postprial gastric function emptying: studies under physiological conditions by combined fiber-optic pressure measurement and MRI. Am J Physiol Gastrointest Liver Physiol 2009;297:G894-901
   PubMed Web of Science ®Google Scholar
• DeSesso JM, Jacobson CF. Anatomical physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem Toxicol 2001;39:209-28
   PubMed Web of Science ®Google Scholar
• Dressman JB. Comparison of canine human gastrointestinal physiology. Pharm Res 1986;3:123-31
   PubMed Web of Science ®Google Scholar
• McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology drug delivery. Int J Pharm 2008;364:213-26
   PubMed Web of Science ®Google Scholar
• Dahan AS, Amidon GL. Gastrointestinal dissolution and absorption of class II drugs. In: Drug bioavailability: estimation of solubility, permeability, absorption and bioavailability. Volume 40 2nd edition. Wiley-VCH Verlag GmbH & Co., KgaA, Germany; 2009. p. 33-51
   Google Scholar
• Lim CL, Byrne C, Lee JK. Human thermoregulation and measurement of body temperature in exercise and clinical settings. Ann Acad Med Singapore 2008;37:347-57
   PubMed Web of Science ®Google Scholar
• Weitschies W, Kosch O, Monnikes H, et al. Magnetic marker monitoring: an application of biomagnetic measurement instrumentation principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv Drug Deliv Rev 2005;57:1210-22
   PubMed Web of Science ®Google Scholar
• McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology drug delivery. Int J Pharm 2008;364:213-26
   PubMed Web of Science ®Google Scholar
• Coupe AJ, Davis SS, Wilding IR. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res 1991;8:360-4
   PubMed Web of Science ®Google Scholar
• Yu LX, Amidon GL. Characterization of small intestinal transit time distribution in humans. Int J Pharm 1998;171:157-63
   Google Scholar
• Arhan P, Devroede G, Jehannin B, et al. Segmental colonic transit-time. Dis Colon Rectum 1981;24:625-9
   PubMed Web of Science ®Google Scholar
• Bouchoucha M, Devroede G, Faye A, et al. Importance of colonic transit evaluation in the management of fecal incontinence. Int J Colorectal Dis 2002;17:412-17
   PubMed Web of Science ®Google Scholar
• Wagener S, Shankar KR, Turnock RR, et al. Colonic transit time - what is normal? J Pediatr Surg 2004;39:166-9
   PubMed Web of Science ®Google Scholar
• Culen M, Rezacova A, Jampilek J, et al. Designing a dynamic dissolution method: a review of instrumental options corresponding physiology of stomach small intestine. J Pharm Sci 2013;102:2995-3017
   PubMed Web of Science ®Google Scholar
• Klein S. The use of biorelevant dissolution media to forecast the in vivo performance of a drug. AAPS J 2010;12:397-406
   PubMed Web of Science ®Google Scholar
• Gray VA, Dressman JB. Change of pH requirements for simulated intestinal fluid TS. Pharmacopeial Forum 1996;22:1943-5
   Google Scholar
• Galia E, Nicolaides E, Horter D, et al. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm Res 1998;15:698-705
   PubMed Web of Science ®Google Scholar
• Vertzoni M, Dressman JB, Butler J, et al. Simulation of fasting gastric conditions its importance for the in vivo dissolution of lipophilic compounds. Eur J Pharm Biopharm 2005;60:413-17
   PubMed Web of Science ®Google Scholar
• Vertzoni M, Pastelli E, Psachoulias D, et al. Estimation of intragastric solubility of drugs: in what medium? Pharm Res 2007;24:909-17
   PubMed Web of Science ®Google Scholar
• Erceg M, Vertzoni M, Cerić H, et al. In vitro vs. canine data for assessing early exposure of doxazosin base and its mesylate salt. Eur J Pharm Biopharm 2012;80:402-9
   PubMed Web of Science ®Google Scholar
• Hofmann AF, Small DM. Detergent properties of bile salts: correlation with physiological function. Annu Rev Med 1967;18:333-76
   PubMed Web of Science ®Google Scholar
• Redinger RN, Small DM. Bile composition, bile-salt metabolism gallstones. Arch Intern Med 1972;130:618-30
   PubMed Web of Science ®Google Scholar
• Carey MC, Small DM. Micelle formation by bile salts: physical-chemical and thermodynamic considerations. Arch Intern Med 1972;130:506-27
   PubMed Web of Science ®Google Scholar
• Klein S, Butler J, Hempenstall JM, et al. Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts. J Pharm Pharmacol 2004;56:605-10
   PubMed Web of Science ®Google Scholar
• Greenwood D. Small intestinal pH and buffer capacity: implications for dissolution of ionizable compounds. Doctoral thesis University of Michigan, Ann Arbor; 1994
   Google Scholar
• Fagerberg JH, Tsinman O, Sun N, et al. Dissolution rate apparent solubility of poorly soluble drugs in biorelevant dissolution media. Mol Pharm 2010;7:1419-30
   PubMed Web of Science ®Google Scholar
• Grove M, Pedersen GP, Nielsen JL, et al. Bioavailability of seocalcitol I: relating solubility in biorelevant media with oral bioavailability in rats – effect of medium and long chain triglycerides. J Pharm Sci 2005;94:1830-8
   PubMed Web of Science ®Google Scholar
• Nielsen FS, Mullertz A. Development of in vitro methods for the evaluation of formulation performance. Bull Tech Gattefossé 2005;98:75-87
   Google Scholar
• Kleberg K, Jacobsen F, Fatouros DG, et al. Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity. J Pharm Sci 2010;99:3522-32
   PubMed Web of Science ®Google Scholar
• Jung H, Milan RC, Girard ME, et al. Bioequivalence study of carbamazepine tablets: in vitro-in vivo correlation. Int J Pharm 1997;152:37-44
   Web of Science ®Google Scholar
• Jantratid E, De Maio V, Ronda E, et al. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form. Eur J Pharm Sci 2009;37:434-41
   PubMed Web of Science ®Google Scholar
• Jonkman JHG. Food interactions with sustained-release theophylline preparations - a review. Clin Pharmacokinet 1989;16:162-79
   PubMed Web of Science ®Google Scholar
• Florence AT, Jani PU. Novel oral-drug formulations - their potential in modulating adverse-effects. Drug Saf 1994;10:233-66
   PubMed Web of Science ®Google Scholar
• Welling PG. Effects of food on drug absorption. Annu Rev Nutr 1996;16:383-415
   PubMed Web of Science ®Google Scholar
• Phuapradit W, Bolton S. The influence of tablet density on the human oral absorption of sustained-release acetaminophen matrix tablets. Drug Dev Ind Pharm 1991;17:1097-107
   Web of Science ®Google Scholar
• Abrahamsson B, Roos K, Sjogren J. Investigation of prandial effects on hydrophilic matrix tablets. Drug Dev Ind Pharm 1999;25:765-71
   PubMed Web of Science ®Google Scholar
• Fleisher D, Li C, Zhou Y, et al. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clin Pharmacokinet 1999;36:233-54
   PubMed Web of Science ®Google Scholar
• Yu LX, Straughn AB, Faustino PJ, et al. The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugs. Mol Pharm 2004;1:357-62
   PubMed Web of Science ®Google Scholar
• Lentz KA. Current methods for predicting human food effect. AAPS J 2008;10:282-8
   PubMed Web of Science ®Google Scholar
• Wilson CG, Washington N. The stomach: its role in drug delivery. In: Rubinstein MH, editor. Physiological Pharmaceutics the stomach: its role in drug delivery. Ellis Horwood Ltd; Chichester: 1989. p. 47-68
   Google Scholar
• Abrahamsson B, Albery T, Eriksson A, et al. Food effects on tablet disintegration. Eur J Pharm Sci 2004;22:165-72
   PubMed Web of Science ®Google Scholar
• Abrahamsson B, Alpsten M, Hugosson M, et al. Absorption, gastrointestinal transit, tablet erosion of felodipine extended-release (ER) tablets. Pharm Res 1993;10:709-14
   PubMed Web of Science ®Google Scholar
• Abrahamsson B, Alpsten M, Bake B, et al. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet effect of food. J Control Release 1998;52:301-10
   PubMed Web of Science ®Google Scholar
• Charman WN, Porter CJH, Mithani S, et al. Physicochemical physiological mechanisms for the effects of food on drug absorption: the role of lipids pH. J Pharm Sci 1997;86:269-82
   PubMed Web of Science ®Google Scholar
• Waltersack IE, Devries JX, Nickel B, et al. The influence of different formula diets different pharmaceutical formulations on the systemic availability of paracetamol, gallbladder size, plasma-glucose. Int J Clin Pharmacol Ther Toxicol 1989;27:544-50
   PubMedGoogle Scholar
• Sunesen VH, Vedelsdal R, Kristensen HG, et al. Effect of liquid volume food intake on the absolute bioavailability of danazol, a poorly soluble drug. Eur J Pharm Sci 2005;24:297-303
   PubMed Web of Science ®Google Scholar
• Leyden JJ. Absorption of minocycline hydrochloride tetracycline hydrochloride - effect of food, milk, iron. J Am Acad Dermatol 1985;12:308-12
   PubMed Web of Science ®Google Scholar
• Klein S. Predicting food effects on drug release from extended-release oral dosage forms containing a narrow therapeutic index drug. Dissol Technol 2009;16:28-40
   Web of Science ®Google Scholar
• Hendeles L, Weinberger M, Milavetz G, et al. Food-induced dose-dumping from a once-a-day theophylline product as a cause of theophylline toxicity. Chest 1985;87:758-65
   PubMed Web of Science ®Google Scholar
• Steffensen G, Pedersen S. Food induced changes in theophylline absorption from a once-a-day theophylline product. Br J Clin Pharmacol 1986;22:571-7
   PubMed Web of Science ®Google Scholar
• Jonkman JHG. Food interactions with once-a-day theophylline preparations - a review. Chronobiol Int 1987;4:449-58
   PubMed Web of Science ®Google Scholar
• Karim A, Burns T, Wearley L, et al. Food-induced changes in theophylline absorption from controlled-release formulations 1 substantial increased decreased absorption with uniphyl tablets theo-dur sprinkle. Clin Pharmacol Ther 1985;38:77-83
   PubMed Web of Science ®Google Scholar
• Marasanapalle VP, Crison JR, Ma J, et al. Investigation of some factors contributing to negative food effects. Biopharm Drug Dispos 2009;30:71-80
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Norouzi-Sani S, Siahi-Shadbad MR, et al. The effect of various surfactants on the release rate of propranolol hydrochloride from hydroxypropylmethylcellulose (HPMC)-eudragit matrices. Eur J Pharm Biopharm 2002;54:349-56
   PubMed Web of Science ®Google Scholar
• Ford JL, Rubinstein MH, McCaul F, et al. Importance of drug type, tablet shape added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Int J Pharm 1987;40:223-34
   Web of Science ®Google Scholar
• Kim H, Fassihi R. Application of binary polymer system in drug release rate modulation 2 influence of formulation variables hydrodynamic conditions on release kinetics. J Pharm Sci 1997;86:323-8
   PubMed Web of Science ®Google Scholar
• Gupta VK, Hariharan M, Wheatley TA, et al. Controlled-release tablets from carrageenans: effect of formulation, storage dissolution factors. Eur J Pharm Biopharm 2001;51:241-8
   PubMed Web of Science ®Google Scholar
• Bettini R, Catellani PL, Santi P, et al. Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility influence on release rate. J Control Release 2001;70:383-91
   PubMed Web of Science ®Google Scholar
• Heng PWS, Chan LW, Easterbrook MG. Investigation of the influence of mean HPMC particle size number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. J Control Release 2001;76:39-49
   PubMed Web of Science ®Google Scholar
• Kaialy W, Emami P, Asare-Addo K, et al. Psyllium: a promising polymer for sustained release formulations in combination with HPMC polymers. Pharm Dev Technol 2014;19:269-77
   PubMed Web of Science ®Google Scholar
• Shojaee S, Asare-Addo K, Kaialy W, et al. An investigation into the stabilization of diltiazem HCl release from matrices made from aged polyox powders. AAPS PharmSciTech 2013;14:1190-8
   PubMed Web of Science ®Google Scholar
• Siahi-Shadbad M, Asare-Addo K, Azizian K, et al. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers. AAPS PharmSciTech 2011;12:1176-82
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Rossi S, Ferrari F, et al. A study of three hydroxypropylmethyl cellulose substitution types: effect of particle size shape on hydrophilic matrix performances. STP Pharma Sci 1996;6:277-84
   Google Scholar
• Velasco MV, Ford JL, Rowe P, et al. Influence of drug: hydroxypropylmethylcellulose ratio, drug polymer particle size compression force on the release of diclofenac sodium from HPMC tablets. J Control Release 1999;57:75-85
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Rubinstein MH, Ford JL. The effects of viscosity grade hydroxypropylmethylcellulose (HPMC) on its compaction properties. J Pharm Pharmacol 1994;46:1075
   Google Scholar
• Nokhodchi A, Rubinstein MH, Ford JL. The effect of particle size viscosity grade on the compaction properties of hydroxypropylmethylcellulose 2208. Int J Pharm 1995;126:189-97
   Web of Science ®Google Scholar
• Aulton ME. Pharmaceutics: the design and manufacture of medicine. Churchill Livingstone; Philadelphia: 2007
   Google Scholar
• Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930-4
   Google Scholar
• Fassihi AR, Munday DL. Dissolution of theophylline from film-coated slow release mini-tablets in various dissolution media. J Pharm Pharmacol 1989;41:369-72
   PubMed Web of Science ®Google Scholar
• Williams RL, Upton RA, Ball L, et al. Development of a new controlled-release formulation of chlorpheniramine maleate using invitro invivo correlations. J Pharm Sci 1991;80:22-5
   PubMed Web of Science ®Google Scholar
• Fassihi RA, Ritschel WA. Multiple-layer, direct-compression, controlled-release system - in-vitro and in-vivo evaluation. J Pharm Sci 1993;82:750-4
   PubMed Web of Science ®Google Scholar
• Gordon MS, Rudraraju VS, Dani K, et al. Effect of the mode of super disintegrant incorporation on dissolution in wet granulated tablets. J Pharm Sci 1993;82:220-6
   PubMed Web of Science ®Google Scholar
• Naylor LJ, Bakatselou V, Dressman JB. Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Pharm Res 1993;10:865-70
   PubMed Web of Science ®Google Scholar
• Omelczuk MO, Mcginity JW. The influence of thermal-treatment on the physical-mechanical and dissolution properties of tablets containing poly(dl-lactic acid). Pharm Res 1993;10:542-8
   PubMed Web of Science ®Google Scholar
• Wang Z, Horikawa T, Hirayama F, et al. Design and in-vitro evaluation of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose. J Pharm Pharmacol 1993;45:942-6
   PubMed Web of Science ®Google Scholar
• de Villiers MM, Van der Watt JG. The measurement of mixture homogeneity and dissolution to predict the degree of drug agglomerate breakdown achieved through powder mixing. Pharm Res 1994;11:1557-61
   PubMed Web of Science ®Google Scholar
• Munday DL, Fassihi AR. In-vitro in-vivo correlation studies on a novel controlled-release theophylline delivery system and on theo-dur tablets. Int J Pharm 1995;118:251-5
   Google Scholar
• Rekhi GS, Jambhekar SS. Bioavailability and in-vitro/in-vivo correlation for propranolol hydrochloride extended-release bead products prepared using aqueous polymeric dispersions. J Pharm Pharmacol 1996;48:1276-84
   PubMed Web of Science ®Google Scholar
• Gouldson MP, Deasy PB. Use of cellulose ether containing excipients with microcrystalline cellulose for the production of pellets containing metformin hydrochloride by the process of extrusion-spheronization. J Microencapsul 1997;14:137-53
   PubMed Web of Science ®Google Scholar
• Diakidou A, Vertzoni M, Abrahamsson B, et al. Simulation of gastric lipolysis prediction of felodipine release from a matrix tablet in the fed stomach. Eur J Pharm Sci 2009;37:133-40
   PubMed Web of Science ®Google Scholar
• Pal A, Indireshkumar K, Schwizer W, et al. Gastric flow mixing studied using computer simulation. Proc Biol Sci 2004;271:2587-94
   PubMed Web of Science ®Google Scholar
• Pillay V, Fassihi AR. Evaluation comparison of dissolution data derived from different modified release dosage forms: an alternative method. J Control Release 1998;55:45-55
   PubMed Web of Science ®Google Scholar
• Khoury N, Mauger JW, Howard S. Dissolution rate studies from a stationary disk rotating fluid system. Pharm Res 1988;5:495-500
   PubMed Web of Science ®Google Scholar
• Bocanegra LM, Morris GJ, Jurewicz JT, Mauger JW. Fluid particle laser doppler velocity-measurements mass-transfer predictions for the USP paddle method dissolution apparatus. Drug Dev Ind Pharm 1990;16:1441-64
   Web of Science ®Google Scholar
• Carino SR, Sperry DC, Hawley M. Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model. J Pharm Sci 2006;95:116-25
   PubMed Web of Science ®Google Scholar
• Cohen JL, Hubert BB, Leeson LJ, et al. The development of USP dissolution drug release stards. Pharm Res 1990;7:983-7
   PubMed Web of Science ®Google Scholar
• Klein S, Rudolph MW, Skalsky B, et al. Use of the BioDis to generate a physiologically relevant IVIVC. J Control Release 2008;130:216-19
   PubMed Web of Science ®Google Scholar
• Fotaki N, Aivaliotis A, Butler J, et al. A comparative study of different release apparatus in generating in vitro–in vivo correlations for extended release formulations. Eur J Pharm Biopharm 2009;73:115-20
   PubMed Web of Science ®Google Scholar
• McAllister M. Dynamic dissolution: a step closer to predictive dissolution testing? Mol Pharm 2010;7:1374-87
   PubMed Web of Science ®Google Scholar
• Diebold SM. Physiological parameters relevant to dissolution testing: hydrodynamic considerations. In: Dressman JB, Kramer J, editors. Pharmaceutical dissolution. Taylor & Francis; London, U.K: 2005. p. 127-91
   Google Scholar
• Fotaki N, Vertzoni M. Biorelevant dissolution methods and their applications in in vitro-in vivo correlations for oral formulations. Open Drug Deliv J 2010;4:2-13
   Google Scholar
• Carino SR, Sperry DC, Hawley M. Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model. J Pharm Sci 2006;95:116-25
   PubMed Web of Science ®Google Scholar
• Gao Y, Carr RA, Spence JK, et al. A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling. Mol Pharm 2010;7:1516-26
   PubMed Web of Science ®Google Scholar
• Gu CH, Rao D, Ghi RB, et al. Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility. J Pharm Sci 2005;94:199-208
   PubMed Web of Science ®Google Scholar
• Garbacz G, Wedemeyer RS, Nagel S, et al. Irregular absorption profiles observed from diclofenac extended release tabletscan be predicted using a dissolution test apparatus that mimics in vivo physical stresses. Eur J Pharm Biopharm 2008;70:421-8
   PubMed Web of Science ®Google Scholar
• Garbacz G, Golke B, Wedemeyer RS, et al. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. Eur J Pharm Sci 2009;38:147-55
   PubMed Web of Science ®Google Scholar
• Kostewicz ES, Wunderlich M, Brauns U, et al. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine. J Pharm Pharmacol 2004;56:43-51
   PubMed Web of Science ®Google Scholar
• Psachoulias D, Vertzoni M, Butler J, et al. An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine. Pharm Res 2012;29:3486-98
   PubMed Web of Science ®Google Scholar
• Vardakou M, Mercuri A, Barker SA, et al. Achieving antral grinding forces in biorelevant in vitro models: comparing the USP dissolution apparatus II the dynamic gastric model with human in vivo data. AAPS PharmSciTech 2011;12:620-6
   PubMed Web of Science ®Google Scholar
• Vardakou M, Mercuri A, Naylor TA, et al. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model. Int J Pharm 2011;419:192-9
   PubMed Web of Science ®Google Scholar
• Mercuri A, Passalacqua A, Wickham MSJ, et al. The effect of composition gastric conditions on the self-emulsification process of ibuprofen loaded self-emulsifying drug delivery systems: a microscopic dynamic gastric model study. Pharm Res 2011;28:1540-51
   PubMed Web of Science ®Google Scholar
• Lo CA, Pitino I, Mandalari G, et al. Survival of probiotic lactobacilli in the upper gastrointestinal tract using an in vitro gastric model of digestion. Food Microbiol 2011;28:1359-66
   PubMed Web of Science ®Google Scholar
• Pitino I, Randazzo CL, Mandalari G, et al. Survival of Lactobacillus rhamnosus strains in the upper gastrointestinal tract. Food Microbiol 2010;27:1121-7
   PubMed Web of Science ®Google Scholar
• Wickham M, Faulks R, Mills C. In vitro digestion methods for assessing the effect of food structure on allergen breakdown. Mol Nutr Food Res 2009;53:952-8
   PubMed Web of Science ®Google Scholar
• Blanquet S, Zeijdner E, Beyssac E, et al. A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm Res 2004;21:585-91
   PubMed Web of Science ®Google Scholar
• Souliman S, Beyssac E, Cardot JM, et al. Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods an artificial digestive system. Drug Dev Ind Pharm 2007;33:475-83
   PubMed Web of Science ®Google Scholar
• Souliman S, Blanquet S, Beysac E, et al. A level A in vitro/in vivo correlation in fasted fed states using different methods: applied to solid immediate release oral dosage form. Eur J Pharm Sci 2006;27:72-9
   PubMed Web of Science ®Google Scholar
• Naylor TA, Connolly PC, Martini LG, et al. Use of a gastro-intestinal model GastroplusTM for the prediction of in vivo performance. Appl Ther Res 2006;6:15-19
   Google Scholar
• Minekus M, Marteau P, Havenaar R, et al. A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine. ATLA 1995;23:197-209
   Google Scholar
• Ronald SH, Gazzaniga A, Sangalli ME, et al. Drug/polymer matrix swelling and dissolution. Pharm Res 1988;5:488-94
   PubMed Web of Science ®Google Scholar
• Colombo P, Bettini R, Massimo G, et al. Drug diffusion front movement is important in drug release control from swellable matrix tablets. J Pharm Sci 1995;84:991-7
   PubMed Web of Science ®Google Scholar
• Colombo P, Bettini R, Santi P, et al. Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport. J Control Release 1996;39:231-7
   Web of Science ®Google Scholar
• Talukdar MM, Kinget R. Swelling and drug release behaviour of xanthan gum matrix tablets. Int J Pharm 1995;120:63-72
   Web of Science ®Google Scholar
• Hodsdon AC, Mitchell JR, Davies MC, et al. Structure behavior in hydrophilic matrix sustained-release dosage forms 3 the influence of ph on the sustained-release performance internal gel structure of sodium alginate matrices. J Control Release 1995;33:143-52
   Web of Science ®Google Scholar
• Mu X, Tobyn MJ, Staniforth JN. Influence of physiological variables on the in vitro drug-release behavior of a polysaccharide matrix controlled-release system. Drug Dev Ind Pharm 2003;29:19-29
   PubMed Web of Science ®Google Scholar
• Johnson JL, Holinej J, Williams MD. Influence of ionic strength on matrix integrity drug release from hydroxypropyl cellulose compacts. Int J Pharm 1993;90:151-9
   Web of Science ®Google Scholar
• Bonferoni MC, Rossi S, Ferrari F, et al. Influence of medium on dissolution-erosion behavior of na carboxymethylcellulose on viscoelastic properties of gels. Int J Pharm 1995;117:41-8
   Web of Science ®Google Scholar
• Mikac U, Sepe A, Kristl J, et al. A new approach combining different MRI methods to provide detailed view on swelling dynamics of xanthan tablets influencing drug release at different pH and ionic strength. J Control Release 2010;145:247-56
   PubMed Web of Science ®Google Scholar
• Kavanagh N, Corrigan OI. Swelling erosion properties of hydroxypropylmethylcellulose (hypromellose) matrices – influence of agitation rate dissolution medium composition. Int J Pharm 2004;279:141-52
   PubMed Web of Science ®Google Scholar
• Schott H. Colloidal dispersions. In: Gennaro AR, editor. Remington: the science practice of pharmacy Philadelphia College of Pharmacy Science. 19th edition. Mack Publishing Co., Easton, PA; 1995. p. 252-77
   Google Scholar
• Sheng JJ, Kasim NA, Chrasekharan R, et al. Solubilization dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant. Eur J Pharm Sci 2006;29:306-14
   PubMed Web of Science ®Google Scholar
• Avdeef A, Barrett DA, Shaw PN, et al. Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates. J Med Chem 1996;39:4377-81
   PubMed Web of Science ®Google Scholar
• Avdeef A. Absorption and drug development: solubility, permeability, and charge state. John Wiley & Son, New Jersey; 2003
   Google Scholar